You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperinsulinism

Showing 1 - 25 of 124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Hyperinsulinism, Insulinoma Trial in Fort Worth (Fluorodopa F 18)

Recruiting
  • Congenital Hyperinsulinism
  • Insulinoma
  • Fluorodopa F 18
  • Fort Worth, Texas
    Cook Children's Medical Center
Dec 8, 2022

Congenital Hyperinsulinism Trial in Worldwide (dasiglucagon)

Enrolling by invitation
  • Congenital Hyperinsulinism
  • Aurora, Colorado
  • +9 more
Jan 30, 2023

Congenital Hyperinsulinism Trial in Worldwide (dasiglucagon, Standard of Care)

Completed
  • Congenital Hyperinsulinism
  • Aurora, Colorado
  • +9 more
Jan 31, 2023

Hyperinsulinism-Hyperammonemia Syndrome Trial in Philadelphia (Vitamin E)

Not yet recruiting
  • Hyperinsulinism-Hyperammonemia Syndrome
  • Vitamin E
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Aug 17, 2022

Congenital Hyperinsulinism Trial in Germany, United Kingdom, United States (HM15136)

Recruiting
  • Congenital Hyperinsulinism
  • Los Angeles, California
  • +7 more
Sep 26, 2022

Insulin Resistance, Polycystic Ovary Syndrome, Hyperinsulinism Trial in Houston

Not yet recruiting
  • Insulin Resistance
  • +4 more
    • Houston, Texas
      Lilli Health
    Jul 10, 2023

    Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Dapagliflozin 10mg
    • New Haven, Connecticut
      Yale Cancer Center Smilow Cancer Hospital
    Aug 3, 2023

    Congenital Hyperinsulinism Trial in Worldwide (dasiglucagon, Placebo)

    Completed
    • Congenital Hyperinsulinism
    • Philadelphia, Pennsylvania
    • +5 more
    Mar 31, 2022

    Congenital Hyperinsulinism Trial in Worldwide (RZ358 Sequential Group Cohort 1, RZ358 Sequential Group Cohort 2, RZ358

    Completed
    • Congenital Hyperinsulinism
    • RZ358 Sequential Group Cohort 1
    • +3 more
    • Philadelphia, Pennsylvania
    • +16 more
    Sep 7, 2022

    Insulin Sensitivity, Glucose Metabolism Disorders (Including Diabetes), Hyperinsulinism Trial in Maastricht (Two day

    Not yet recruiting
    • Insulin Sensitivity
    • +2 more
    • Two day supplementation of a complex fiber mixture
    • Placebo supplementation
    • Maastricht, Netherlands
    • +1 more
    Mar 1, 2023

    Glucose, High Blood, Exercise-Induced Hyperinsulinism Trial in Toledo (TYPE OF EXERCISE (OR REST))

    Enrolling by invitation
    • Glucose, High Blood
    • Exercise-Induced Hyperinsulinism
    • TYPE OF EXERCISE (OR REST)
    • Toledo, Spain
      University of Castilla-La Mancha (Exercise Physiology Lab)
    Nov 3, 2022

    Markers of Inflammation, Hyperglycemia, Postprandial, Hyperinsulinism Trial in Tlaquepaque (Effect of a Hibiscus sabdariffa

    Recruiting
    • Markers of Inflammation
    • +2 more
    • Effect of a Hibiscus sabdariffa beverage
    • Tlaquepaque, Jalisco, Mexico
      ITESO
    Mar 7, 2023

    Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced Trial in Haifa (Pioglitazone)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Haifa, Israel
      Rambam Health Care Campus
    Feb 22, 2023

    Congenital Hyperinsulinism, Neuroblastoma, Parkinson Disease Trial in Edmonton (18F-DOPA, Furosemide Injection)

    Recruiting
    • Congenital Hyperinsulinism
    • +5 more
    • Edmonton, Alberta, Canada
      WC Mackenzie Health Science Centre / University of Alberta Hospi
    Apr 11, 2022

    type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)

    Recruiting
    • type1diabetes
    • +3 more
    • Parma, Pr, Italy
      Azienda Ospedaliero Universitaria di Parma
    Dec 20, 2022

    Hyperinsulinism Trial in Saint Louis (18F-Fluoro Dopa PET/MRI Imaging)

    Recruiting
    • Hyperinsulinism
    • 18F-Fluoro Dopa PET/MRI Imaging
    • Saint Louis, Missouri
      Washington University
    Oct 8, 2021

    Hyperinsulinemia, PreDiabetes Trial in Basel (Anakinra, Placebo)

    Not yet recruiting
    • Hyperinsulinemia
    • PreDiabetes
    • Basel, Switzerland
      University Hospital Basel
    May 2, 2023

    Insulin Resistance, Hyperinsulinism, Immune System Trial in Nîmes (Blood test)

    Recruiting
    • Insulin Resistance
    • +2 more
    • Blood test
    • Nîmes, Gard, France
    • +1 more
    Sep 23, 2022

    Congenital Hyperinsulinism (CHI), Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI) Trial in Philadelphia (18 F-DOPA)

    Completed
    Has Results
    • Congenital Hyperinsulinism (CHI)
    • Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
    • 18 F-DOPA
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Oct 14, 2021

    Insulin Resistance, Depression, Depressive Disorder Trial (Cognitive-Behavioral Therapy followed by Exercise Training, Exercise

    Not yet recruiting
    • Insulin Resistance
    • +7 more
    • Cognitive-Behavioral Therapy followed by Exercise Training
    • +3 more
    • (no location specified)
    Sep 13, 2022

    Congenital Hyperinsulinism, Insulinoma, Hyperinsulinism Trial (Pasireotide 0.6Mg Solution for Injection, Saline Solution)

    Withdrawn
    • Congenital Hyperinsulinism
    • +2 more
    • Pasireotide 0.6Mg Solution for Injection
    • Saline Solution
    • (no location specified)
    May 12, 2021

    Obesity, Hypoglycemia Post Gastric Bypass Surgery, Hyperinsulinemic Hypoglycemia Trial in Arnhem (GLP-1R PET)

    Recruiting
    • Obesity
    • +2 more
    • GLP-1R PET
    • Arnhem, Netherlands
      Rijnstate hospital
    Oct 27, 2022

    Insulin Resistance, Hyperinsulinemia, Dyslipidemias Trial in New York (drug, device, diagnostic test, dietary supplement)

    Recruiting
    • Insulin Resistance
    • +2 more
    • Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg)
    • +4 more
    • New York, New York
      Columbia University Irving Medical Center
    Feb 3, 2023

    Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per

    Recruiting
    • Hyperinsulinemia
    • +3 more
    • Diazoxide oral suspension, 1 mg per kg per dose
    • +3 more
    • New York, New York
      Columbia University Irving Medical Center
    Feb 6, 2023

    Primary Aldosteronism in Blacks

    Recruiting
    • Adrenal Gland Neoplasm
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 11, 2022